Drugs / SUNPHENON EGCg
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02832271 Comparator | Dec 2016 → Dec 2022 | endometriosis | Chinese University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SUNPHENON EGCg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02832271 ↗ |
| Route | Oral | “SUNPHENON EGCg Oral, 400mg, twice per day” NCT02832271 ↗ |